Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Lilly

Status and phase: Completed; Phase 3

Conditions: Urinary Incontinence Stress

Treatments: Drug: Duloxetine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00191204

F1J-MC-SBBM

5309

Details and patient eligibility

About

The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female out patients
• Are ambulatory and are able to use a toilet independently and without difficulty.

Exclusion criteria

• Use of monoamine oxidase inhibitors (MAOIs)

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)